Nicole S Nevadunsky
Overview
Explore the profile of Nicole S Nevadunsky including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
360
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fife A, Najor A, Aspir T, Haines K, Vilardo N, Isani S, et al.
Gynecol Oncol
. 2024 Jan;
182:115-120.
PMID: 38262233
Objective: We aimed to characterize delays to care in patients with endometrioid endometrial cancer and the role healthcare access plays in these delays. Methods: A chart review was performed of...
2.
Scanlon L, Khaksari B, Goel S, Nevadunsky N, Wright J, Gressel G
Gynecol Oncol
. 2023 Apr;
173:68-73.
PMID: 37105059
Background: Cancer associated venous thromboembolism (VTE) is associated with significant morbidity and mortality. Direct oral anticoagulants (DOACs) have emerged as alternatives to injectable medications for both thromboprophylaxis and treatment of...
3.
Borczuk R, Scanlon L, Pease G, Erlichman D, Nevadunsky N
Gynecol Oncol Rep
. 2022 Apr;
40:100954.
PMID: 35359490
Objectives: The purpose of this report was to present the diagnosis and management of an unusual case of a woman with ovarian carcinoma who developed an isolated recurrence to the...
4.
Samuel D, Nevadunsky N, Miller D, Isani S, Kuo D, Gressel G
Curr Probl Cancer
. 2020 Sep;
45(2):100655.
PMID: 32994074
The use of opioids across all specialties has increased greatly over the last 2 decades and along with it, opioid misuse, overdose and death. The contribution of opioids prescribed for...
5.
Tymon-Rosario J, Miller D, Novetsky A, Goldberg G, Nevadunsky N, Makhija S, et al.
Gynecol Oncol
. 2020 Mar;
157(3):723-728.
PMID: 32217003
Background: The risk factors for extended length of stay (LOS) have not been examined in a cohort of patients with complex social and medical barriers who undergo robotic assisted (RA)...
6.
Van Arsdale A, Miller D, Kuo D, Isani S, Sanchez L, Nevadunsky N
Gynecol Oncol
. 2019 May;
154(1):156-162.
PMID: 31060820
Background: Obesity confers an overall increased risk for development of endometrial cancer. However there are conflicting reports regarding the effect of obesity on patients' overall and disease specific survival. The...
7.
Gressel G, Dioun S, Richley M, Lounsbury D, Rapkin B, Isani S, et al.
Gynecol Oncol
. 2019 Mar;
152(3):509-513.
PMID: 30876496
Objective: The Patient-Reported Outcomes Measurement Information System (PROMIS®) Network has developed a comprehensive repository of electronic patient reported outcomes measures (ePROs) of major symptom domains that have been validated in...
8.
Tymon-Rosario J, Miller E, Gressel G, Nevadunsky N
Gynecol Oncol Rep
. 2018 Nov;
26:94-98.
PMID: 30456286
•Diabetes mellitus confers worse survival in women with granulosa cell tumors.•Routine lymphadenectomy does not improve survival in women with granulosa cell tumors.•Women in this cohort had a high prevalence of...
9.
Gressel G, Turker L, Dioun S, McGinn A, Nevadunsky N
Obstet Gynecol
. 2018 Oct;
132(5):1130-1136.
PMID: 30303906
Objective: To characterize risk factors and timing of venous thromboembolism in women with uterine serous carcinoma. Methods: A retrospective cohort study was performed including all women diagnosed with uterine serous...
10.
Dioun S, Jorgensen J, Miller E, Tymon-Rosario J, Xie X, Xue X, et al.
Gynecol Oncol
. 2018 Aug;
151(1):134-140.
PMID: 30149897
Objectives: Unplanned hospital admission following chemotherapy is a measure of quality cancer care. Large retrospective datasets have shown admission rates of 10-35% for women with ovarian cancer receiving chemotherapy. We...